Highlights

01/06 CVS Group plc commences an Equity Buyback Plan for 7,174,031 shares, representing 10.04% of its issued share capital, under the authorization approved on November 18, 2025. CI
26/05 CVS says refinancing provides extra "firepower" as launches buyback AN
26/05 CVS Group Buys Animal Practice in Australia for AU$8 Million MT
26/05 Kingfisher backs guidance; CVS Group launches buyback AN
26/05 CVS Group to Launch GBP50 Million Share Buyback Program MT
26/05 CVS Group launches £50M share buyback programme RE
13/05 Converium Capital Sends Letter to CVS Group CI
13/05 Activist pressures CVS to buy back GBP100 million in shares AN
13/05 Activist investor pressures CVS to buy back GBP100 million in shares AN
13/05 Activist Shareholder Urges CVS Board to Launch GBP100 Million Stock Buyback MT
13/05 Activist fund Converium urges UK vet group CVS to initiate stock buyback RE
30/03 CVS Group CEO to step down as UK vet pricing probe concludes AN
24/03 CVS Group Welcomes UK CMA's Final Decision Summary on Veterinary Services Market Probe MT
24/03 CMA forces vets to publish prices, caps fees as sector hails probe end AN
24/03 Competition and Mkts says CMA concludes investigation into veterinary sector RE
24/03 UK pet owners to get price comparison tools, fee caps under new vet services rules RE
26/02 CVS Group profit falls in first half as "softer" UK market persists AN
26/02 CVS Group plc Reports Earnings Results for the Half Year Ended December 31, 2025 CI
26/02 CVS Group Books Lower Fiscal H1 Profit; Revenue Up MT
26/02 Earnings Flash (CVSG.L) CVS Group Posts Fiscal H1 EPS GBX10.9 MT
26/02 Earnings Flash (CVSG.L) CVS Group Reports Fiscal H1 Revenue GBP356.9M MT
17/02 Kelso Group Invests in Veterinary Company CVS Group MT
28/01 CVS Group to Assist DEFRA in Consultation Over Proposed Vet Market Reforms MT
28/01 CVS Group engages with Defra and CMA on VSA reforms RE
23/01 CVS Group sees interim revenue rise ahead of AIM exit AN
No results match your criteria